Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study

被引:0
|
作者
van der Heijde, Desiree [1 ]
Dougados, Maxime [2 ]
Maksymowych, Walter [3 ]
Bergman, Gina [4 ]
Curtis, Sean P. [4 ]
Tzontcheva, Anjela [4 ]
Philip, George [4 ]
Huyck, Susan [4 ]
Sieper, Joachim [5 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Paris Descartes Univ, Paris, France
[3] Univ Alberta, Edmonton, AB, Canada
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Univ Clin Benjamin Franklin, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2854
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
  • [22] EFFICACY OF ADALIMUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS OF AN INVESTIGATOR-INITIATED 12-WEEKS RANDOMIZED DOUBLE-BLIND PLACEBO CONTROLLED TRIAL WITH A 12 WEEKS OPEN-LABEL EXTENSION PHASE
    Pedersen, S. J.
    Sorensen, I. J.
    Loft, A. G.
    Hindrup, J. S.
    Thamsborg, G.
    Asmussen, K.
    Kluger, E.
    Norregaard, J.
    Christensen, T. G.
    Jurik, A. G.
    Moller, J. M.
    Hasselquist, M.
    Skjodt, T.
    Mikkelsen, D.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 289 - 289
  • [23] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
    van der Heijde, Desiree
    Deodhar, Atul
    Maksymowych, Walter P.
    Sieper, Joachim
    van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Duan, Yuanyuan
    Chu, Alvina D.
    Song, In-Ho
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 26 - 26
  • [24] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 1-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
    Deodhar, Atul
    van der Heijde, Desiree
    Sieper, Joachim
    Van den Bosch, Filip
    Maksymowych, Walter
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina D.
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension
    van der Heijde, Desiree
    Deodhar, Atul
    Maksymowych, Walter
    Sieper, Joachim
    Van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Duan, Yuanyuan
    Chu, Alvina D.
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1925 - 1928
  • [26] Efficacy and Safety of Upadacitinib in Patients With Active Ankylosing Spondylitis: 1-Year Results From a Randomized, Double-Blind, Placebo-Controlled Study With Open-Label Extension
    Maksymowych, Walter
    van der Heijde, Desiree
    Sieper, Joachim
    van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew
    Combe, Bernard
    Sui, Yunxia
    Wang, Xin
    Chu, Alvina
    Song, In-Ho
    Deodhar, Atul
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1122 - 1122
  • [27] EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 1-YEAR RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH OPEN-LABEL EXTENSION
    Deodhar, A.
    Van der Heijde, D.
    Sieper, J.
    Van den Bosch, F.
    Maksymowych, W. P.
    Kim, T. H.
    Kishimoto, M.
    Ostor, A.
    Combe, B.
    Sui, Y.
    Wang, X.
    Chu, A.
    Song, I. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 85 - 86
  • [28] Long-Term Efficacy of Benralizumab in Patients with Severe Asthma Directly Transitioning from the ANDHI Double-Blind to the ANDHI in Practice Open-Label Extension Substudy
    Harrison, T.
    Katial, R.
    Lugogo, N. L.
    Burden, A.
    Kwiatek, J.
    Louis, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [29] LONG-TERM TOLERABILITY OF ZONISAMIDE IN PAEDIATRIC PATIENTS WITH EPILEPSY: RESULTS OF A PHASE II, OPEN-LABEL, EXTENSION STUDY
    Chouette, I.
    Giorgi, L.
    EPILEPSIA, 2012, 53 : 53 - 53
  • [30] Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
    Cutler, Andrew J.
    Kalali, Amir H.
    Mattingly, Greg W.
    Kunovac, Jelena
    Meng, Xiangyi
    CNS SPECTRUMS, 2013, 18 (01) : 43 - 54